Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid symbols : Tomdf save search
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
Published: 2023-09-26 (Crawled : 15:30) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -16.67%
covid medical
Todos Medical Supports Long COVID Awareness Day
Published: 2023-03-15 (Crawled : 19:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: -33.33%
H: 60.0%
C: 30.0%
day covid medical
Todos Medical Announces Preprint of Long COVID Case Study Participant with Confirmed Microclot and Hyperactivated Platelets who Benefitted from Tollovid
Published: 2022-09-15 (Crawled : 13:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 0.95%
H: 0.0%
C: -8.92%
covid tollovid study
Todos Medical CEO Discusses Long COVID Economic Impact with Moneta Advisory Managing Partner Marc LoPresti
Published: 2022-09-09 (Crawled : 17:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 3.78%
H: 0.0%
C: -17.81%
ceo covid impact
Todos Medical Expands COVID Onsite School Sample Collection to Include MonkeyPox Testing
Published: 2022-08-29 (Crawled : 13:20) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: -1.23%
H: 5.0%
C: -5.75%
monkeypox covid
Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
Published: 2022-08-25 (Crawled : 12:00) - biospace.com/
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 0.0%
H: 6.46%
C: 3.93%
monkeypox covid diagnostics study
Todos Medical Announces Preprint of Data from First 100 Participants in IRB-waived Market Research Study of Supplementation with Tollovid in Long COVID
Published: 2022-08-19 (Crawled : 13:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 0.0%
H: 10.42%
C: 4.17%
research covid tollovid 100 study market
Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID
Published: 2022-08-15 (Crawled : 14:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 1.59%
H: 21.88%
C: -12.5%
covid-19 covid mrna tollovid publication
Todos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study in Adults
Published: 2022-08-11 (Crawled : 13:20) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 17.06%
H: 0.0%
C: -9.14%
covid trial study
Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics
Published: 2022-08-05 (Crawled : 18:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 8.89%
H: 7.76%
C: -12.65%
partnership covid services biomarker diagnostics agreement
Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel
Published: 2022-07-28 (Crawled : 12:00) - biospace.com/
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: -3.36%
H: 4.35%
C: 3.48%
covid biomarker diagnostics
Todos Medical Announces Preprint of Chronic Long COVID Case Study #8 of Paxlovid® Treatment Followed by Tollovid™ Dietary Supplementation
Published: 2022-07-22 (Crawled : 14:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 0.0%
H: 2.5%
C: -2.5%
paxlovid treatment covid study
Todos Medical Reports Case Study #7 in Acute and Long COVID
Published: 2022-07-12 (Crawled : 14:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: -1.67%
H: 5.08%
C: 1.69%
covid study
Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID
Published: 2022-06-23 (Crawled : 12:00) - biospace.com/
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 2.42%
H: 9.45%
C: 1.57%
tollovid research covid market
Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study
Published: 2022-04-20 (Crawled : 12:20) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 2.13%
H: 9.03%
C: -2.78%
covid tollovid
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate of Free Sale with Daily and Acute Dosing on the Label
Published: 2022-04-06 (Crawled : 13:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: -4.76%
H: 16.25%
C: 15.63%
tollovid fda covid label
Todos Medical Reports Case Study of Patient with Long COVID
Published: 2022-03-31 (Crawled : 15:20) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 3.13%
H: 6.06%
C: 0.0%
covid
Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients
Published: 2022-01-27 (Crawled : 14:00) - biospace.com/
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 12.52%
H: 7.57%
C: -22.72%
covid-19 treatment phase 2 trial covid tollovir antiviral
Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
Published: 2022-01-24 (Crawled : 14:00) - biospace.com/
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 10.0%
H: 7.27%
C: -1.82%
covid-19 treatment phase 2 trial covid tollovir
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
Published: 2022-01-12 (Crawled : 15:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 5.45%
H: 20.83%
C: 1.67%
covid-19 treatment phase 2 trial covid tollovir topline results results topline
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.